Exos Tfp Holdings LLC Eli Lilly & CO Transaction History

Exos Tfp Holdings LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $686,802 - $806,617	2,211 Added 108.86%	4,242 $1.46 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $790,048 - $920,564	-2,457 Reduced 54.75%	2,031 $743,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.33 Million - $1.52 Million	4,488 New	4,488 $1.45 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Exos Tfp Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Exos Tfp Holdings LLC with notifications on news.